Stay updated on LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial page.

Latest updates to the LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page footer, indicating a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedA new note states that PubMed-listed publications are auto-filled and may not all relate to the study, and the page now shows revision: v3.3.1; the older PubMed wording and revision v3.2.0 have been removed.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved the general government funding and operating status notice. This does not affect the study details, eligibility criteria, or data presented on the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedRemoved the 'Type 1 diabetes' topic and the 'MedlinePlus Genetics' related topics section from the page.SummaryDifference0.1%

- Check35 days agoChange DetectedAdded Type 1 diabetes and MedlinePlus Genetics as related topics on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check64 days agoChange DetectedUpdate adds a government-funding status notice and NIH Clinical Center operating details with a v3.2.0 revision, while removing the old v3.1.0 tag.SummaryDifference3%

Stay in the know with updates to LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial page.